Association Between Dose and Duration of Cisplatin Exposure with Cytotoxicity Effect on Nasopharyngeal Carcinoma Stem Cell

  • Laksmi Kusuma Wardhani
  • Widodo Ario KentjonoEmail author
  • Achmad Chusnu Romdhoni
Original Article


Nasopharyngeal carcinoma (NPC) is ranked 6th of malignant tumors in Indonesia. To analyze the correlation of dose and duration of cisplatin exposure with cytotoxic effects on nasopharyngeal carcinoma stem cells. The biopsy NPC tissue was cultured and processed to obtain NPC stem cells to be treated with cisplatin different doses and durations (24 and 48 h). The number of dead cells after exposure will be calculated using a hemocytometer. Death stem cell density of NPC at exposure of 2 μg/ml cisplatin dose was 81.37%, while the smallest death cell density a dose of 0.05 μg/ml after a 72-h observation was 21.3%. The coefficient correlation 0.827 and value p = 0.000 (p < 0.05). The analysis of the correlation between cisplatin exposure duration and death cell was also significant with the correlation coefficient − 0.357 and the value p = 0.001 (p < 0.05). There was a correlation between the increased dose of cisplatin with the cytotoxicity effects on NPC stem cell.


Nasopharyngeal carcinoma (NPC) Dose Duration of exposure Cisplatin Cytotoxicity 


  1. 1.
    Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S et al (2012) Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 31(4):185–196CrossRefGoogle Scholar
  2. 2.
    Roezin A, Syafril A (2006) Buku ajar Ilmu Penyakit Telinga Hidung Tenggorok. Edisi kelima. Jakarta, FKUIGoogle Scholar
  3. 3.
    Longo-Sorbello G, Saydam G, Banerjee D, Bertino J (2006) Cytotoxicity and cell growth assays. In: Celis J, Charter N, Simons K, Small J, Hunter T, Shotton D (eds) Cell biology, four-volume set: a laboratory handbook, vol 1, 3rd edn. Academic Press, Amsterdam, pp 315–324Google Scholar
  4. 4.
    Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99(9):2467–2498CrossRefGoogle Scholar
  5. 5.
    Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM (2007) Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7(1):3–18CrossRefGoogle Scholar
  6. 6.
    Chan AT, Teo PM, Leung TW, Leung SF, Lee WY, Yeo W et al (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33(3):569–577CrossRefGoogle Scholar
  7. 7.
    Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ et al (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 19(5):1350–1357CrossRefGoogle Scholar
  8. 8.
    Monroe MM, Anderson EC, Clayburgh DR, Wong MH (2011) Cancer stem cells in head and neck squamous cell carcinoma. J Oncol 2011:762780CrossRefGoogle Scholar
  9. 9.
    Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN et al (2008) Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Can Res 68(9):3243–3250CrossRefGoogle Scholar
  10. 10.
    Troger V, Fischel JL, Formento P, Gioanni J, Milano G (1992) Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration. Eur J Cancer 28(1):82–86CrossRefGoogle Scholar
  11. 11.
    Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A et al (2003) Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin Cancer Res Off J Am Assoc Cancer Res 9(15):5756–5767Google Scholar
  12. 12.
    Wu YJ, Muldoon LL, Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312(2):424–431CrossRefGoogle Scholar
  13. 13.
    Hong JY, Kim GH, Kim JW, Kwon SS, Sato EF, Cho KH et al (2012) Computational modeling of apoptotic signaling pathways induced by cisplatin. BMC Syst Biol 6:122CrossRefGoogle Scholar
  14. 14.
    Hanigan MH, Deng M, Zhang L, Taylor PT Jr, Lapus MG (2005) Stress response inhibits the nephrotoxicity of cisplatin. Am J Physiol Renal Physiol 288(1):F125–F132CrossRefGoogle Scholar
  15. 15.
    Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 17(12):2763–2769CrossRefGoogle Scholar
  16. 16.
    Fanning J, Biddle WC, Goldrosen M, Crickard K, Crickard U, Piver MS et al (1990) Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecol Oncol 39(2):119–122CrossRefGoogle Scholar
  17. 17.
    Leist M, Nicotera P (1997) The shape of death cell. Biochem Biophys Res Commun 236(1):1–9CrossRefGoogle Scholar
  18. 18.
    Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol JASN 13(4):858–865PubMedGoogle Scholar
  19. 19.
    Martelli L, Ragazzi E, Di Mario F, Basato M, Martelli M (2009) Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency. Anticancer Res 29(10):3931–3937PubMedGoogle Scholar
  20. 20.
    Liao SK, Perng YP, Shen YC, Chung PJ, Chang YS, Wang CH (1998) Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet Cytogenet 103(1):52–58CrossRefGoogle Scholar
  21. 21.
    Nilsson JR (2008) Cytotoxic effect of cisplatin on Tetrahymena. J Cell Sci 90:707–716Google Scholar
  22. 22.
    Masters RW (2000) Animal cell culture, trypan blue assay sop, 3rd edn. JB Lippincott, PhiladelphiaGoogle Scholar
  23. 23.
    Wang X, Wong SC, Pan J, Tsao SW, Fung KH, Kwong DL et al (1998) Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Can Res 58(22):5019–5022Google Scholar

Copyright information

© Association of Otolaryngologists of India 2018

Authors and Affiliations

  • Laksmi Kusuma Wardhani
    • 1
  • Widodo Ario Kentjono
    • 1
    Email author
  • Achmad Chusnu Romdhoni
    • 1
  1. 1.Department of OtorhinolaryngologyFaculty of Medicine Universitas Airlangga - Dr. Soetomo General HospitalSurabayaIndonesia

Personalised recommendations